Encoded Therapeutics Inc.
Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.
$275MSeries F
ParticipantV
Venrock
Activity from announced rounds
Activity in this selectionoxford-innovation-finance-03f5fb23
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $419M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionGitar
Builds AI agents for code review and continuous integration workflows
$9MUndisclosed
Role not disclosedAdcendo
Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.
$75MSeries C
Role not disclosedGenLogs
Provides a truck intelligence platform using roadside sensors and AI to secure freight networks
$60MSeries B
Role not disclosed